Skip Navigation

Cardiovascular Research 2005 65(2):436-445; doi:10.1016/j.cardiores.2004.10.009
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rorabaugh, B. R.
Right arrow Articles by Perez, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rorabaugh, B. R.
Right arrow Articles by Perez, D. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

{alpha}1A- but not {alpha}1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism

Boyd R. Rorabaugha, Sean A. Rossa,1, Robert J. Gaivina, Robert S. Papaya, Dan F. McCunea, Paul C. Simpsonb and Dianne M. Pereza,*

aDepartment of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195, USA
bDepartment of Cardiology, University of California, San Francisco, CA 94143, United States

* Corresponding author. Tel.: +1 216 444 2058; fax: +1 216 444 9263. Email address: perezd{at}ccf.org

Objective: Brief periods of ischemia stimulate an endogenous mechanism in the heart that protects the myocardium from subsequent ischemic injury. {alpha}1-Adrenergic receptors (ARs) have been implicated in this process. However, the lack of sufficiently selective antagonists has made it difficult to determine which {alpha}1-AR subtype protects the heart from ischemic injury. The goal of this study was to identify the {alpha}1-AR subtype that is involved in ischemic preconditioning.

Methods: We developed transgenic mice that express constitutively active mutant (CAM) forms of the {alpha}1A-AR or the {alpha}1B-AR regulated by their endogenous promoters. Hearts isolated from transgenic and non-transgenic mice were perfused by the Langendorff method using an ischemic preconditioning perfusion protocol or a non-preconditioning perfusion protocol prior to 30-min ischemia and 40-min reperfusion. Contractile function was continuously monitored through an intraventricular balloon.

Results: The contractile function of non-transgenic hearts perfused according to the ischemic preconditioning protocol completely recovered from 30-min ischemia. However, non-transgenic hearts perfused according to the non-preconditioning protocol recovered only 60% of their contractile function. The contractile function of CAM {alpha}1A-AR hearts, but not CAM {alpha}1B-AR hearts, completely recovered from 30-min ischemia even though they were perfused according to the non-preconditioning protocol. Thus, CAM {alpha}1A-AR hearts, but not CAM {alpha}1B-AR hearts, were inherently preconditioned against ischemic injury. Staurosporine, but not chelerythrine, completely reversed the preconditioning effect of CAM {alpha}1A-ARs.

Conclusions: These data demonstrate that {alpha}1A-ARs protect the heart from ischemic injury through a staurosporine-sensitive signaling pathway that is independent of protein kinase C.

KEYWORDS Alpha 1 adrenergic receptors; Ischemic preconditioning; Transgenic mouse; Ischemia


1 Current address: GlaxoSmithKline, Research Triangle Park, NC, United States.

Time for primary review 24 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
D. M. Perez, R. S. Papay, and T. Shi
{alpha}1-Adrenergic Receptor Stimulates Interleukin-6 Expression and Secretion through Both mRNA Stability and Transcriptional Regulation: Involvement of p38 Mitogen-Activated Protein Kinase and Nuclear Factor-{kappa}B
Mol. Pharmacol., July 1, 2009; 76(1): 144 - 152.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. M. Tsutsumi, Y. T. Horikawa, M. M. Jennings, M. W. Kidd, I. R. Niesman, U. Yokoyama, B. P. Head, Y. Hagiwara, Y. Ishikawa, A. Miyanohara, et al.
Cardiac-Specific Overexpression of Caveolin-3 Induces Endogenous Cardiac Protection by Mimicking Ischemic Preconditioning
Circulation, November 4, 2008; 118(19): 1979 - 1988.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. A. Woodcock, X.-J. Du, M. E. Reichelt, and R. M. Graham
Cardiac {alpha}1-adrenergic drive in pathological remodelling
Cardiovasc Res, February 1, 2008; 77(3): 452 - 462.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Gao, L. Chen, and H.-T. Yang
Activation of {alpha}1B-adrenoceptors alleviates ischemia/reperfusion injury by limitation of mitochondrial Ca2+ overload in cardiomyocytes
Cardiovasc Res, August 1, 2007; 75(3): 584 - 595.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Huang, C. D. Wright, C. L. Merkwan, N. L. Baye, Q. Liang, P. C. Simpson, and T. D. O'Connell
An {alpha}1A-Adrenergic-Extracellular Signal-Regulated Kinase Survival Signaling Pathway in Cardiac Myocytes
Circulation, February 13, 2007; 115(6): 763 - 772.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. K. Kudej, Y.-T. Shen, A. P. Peppas, C.-H. Huang, W. Chen, L. Yan, D. E. Vatner, and S. F. Vatner
Obligatory Role of Cardiac Nerves and {alpha}1-Adrenergic Receptors for the Second Window of Ischemic Preconditioning in Conscious Pigs
Circ. Res., November 24, 2006; 99(11): 1270 - 1276.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.